Literature DB >> 18987366

Saying no isn't NICE - the travails of Britain's National Institute for Health and Clinical Excellence.

Robert Steinbrook1.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18987366     DOI: 10.1056/NEJMp0806862

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  A multicenter, prospective, advanced diagnostic bronchoscopy outcomes registry.

Authors:  Armin Ernst; Michael Simoff; David Ost; Gaetane Michaud; Divay Chandra; Felix J F Herth
Journal:  Chest       Date:  2010-04-02       Impact factor: 9.410

2.  Should cost considerations be included in medical decisions? No.

Authors:  Bin Du; Jeremy M Kahn
Journal:  Intensive Care Med       Date:  2015-07-28       Impact factor: 17.440

3.  Public financing of the Medicare program will make its uniform structure increasingly costly to sustain.

Authors:  Katherine Baicker; Mark Shepard; Jonathan Skinner
Journal:  Health Aff (Millwood)       Date:  2013-05       Impact factor: 6.301

Review 4.  Systematic reviews and health policy: the influence of a project on perinatal care since 1988.

Authors:  Daniel M Fox
Journal:  Milbank Q       Date:  2011-09       Impact factor: 4.911

5.  Integrating pharmacogenetics and therapeutic drug monitoring: optimal dosing of imatinib as a case-example.

Authors:  Alain Li-Wan-Po; Peter Farndon; Charles Craddock; Michael Griffiths
Journal:  Eur J Clin Pharmacol       Date:  2010-01-29       Impact factor: 2.953

6.  Initial patterns of care with oral targeted therapies for patients with renal cell carcinoma.

Authors:  Christopher P Filson; Bruce G Redman; Rodney L Dunn; David C Miller
Journal:  Urology       Date:  2011-01-22       Impact factor: 2.649

7.  Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.

Authors:  Rena Conti; David L Veenstra; Katrina Armstrong; Lawrence J Lesko; Scott D Grosse
Journal:  Med Decis Making       Date:  2010-01-04       Impact factor: 2.583

8.  Improving quality and diffusing best practices: the case of schizophrenia.

Authors:  Marcela Horvitz-Lennon; Julie M Donohue; Marisa E Domino; Sharon-Lise T Normand
Journal:  Health Aff (Millwood)       Date:  2009 May-Jun       Impact factor: 6.301

9.  How do the efficacy and safety of abatacept and infliximab compare in the treatment of active RA?

Authors:  Peter C Taylor
Journal:  Nat Clin Pract Rheumatol       Date:  2009-03

10.  Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement.

Authors:  Vicki C Tse; Wai Tong Ng; Victor Lee; Anne W M Lee; Daniel T T Chua; June Chau; Sarah M McGhee
Journal:  BMC Cancer       Date:  2011-07-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.